Hong Shi
Impact in
- Hepatology top 10%
- Hepatitis C virus research
- Hematology top 10%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
Papers in
- Epidemiology 16
- Hepatitis B Virus Studies 16
- Liver Disease Diagnosis and Treatment 15
- Hepatology 16
- Hepatitis C virus research 14
- Liver Disease and Transplantation 2
- Co-authors
- Richard Gedrich (2 shared papers)Amy Burd (2 shared papers)Laura Abriola (1 shared paper)S M Wilhelm (1 shared paper)Hema Vasavada (1 shared paper)David F. Miller (1 shared paper)Dean Wilkie (1 shared paper)W C Pickett (1 shared paper)
- Journals
- BioMed Research International (2 papers)JAMA Network Open (1 paper)Leukemia (1 paper)Science Bulletin (1 paper)Journal of Medical Internet Research (1 paper)
- Partner nations
- ChinaUnited StatesSingapore
In The Last Decade
Hong Shi
26 papers receiving 325 citations
Peers
Comparison fields: 5 of 78
- Hepatology 75
- Hematology 94
- Genetics 41
- Epidemiology 92
- Molecular Biology 110
Countries citing papers authored by Hong Shi
This map shows the geographic impact of Hong Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hong Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hong Shi more than expected).
Fields of papers citing papers by Hong Shi
This network shows the impact of papers produced by Hong Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hong Shi. The network helps show where Hong Shi may publish in the future.
Co-authors
The 25 scholars most cited alongside Hong Shi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 134 | |
| 2 | 2009 | 31 | |
| 3 | 2015 | 17 | |
| 4 | 2016 | 16 | |
| 5 | 2023 | 16 | |
| 6 | 2016 | 13 | |
| 7 | Comparison of the efficacy of tenofovir disoproxil fumarate and entecavir for initial treatment of patient with chronic hepatitis B in China. | 2015 | 12 |
| 8 | 2023 | 11 | |
| 9 | 2022 | 9 | |
| 10 | [Value of FIB-4 for the diagnosis of liver fibrosis in chronic hepatitis B]. | 2010 | 9 |
| 11 | 2013 | 8 | |
| 12 | 2022 | 8 | |
| 13 | 2017 | 8 | |
| 14 | Optimized combination therapies with adefovir dipivoxil (ADV) and lamivudine, telbivudine, or entecavir may be effective for chronic hepatitis B patients with a suboptimal response to ADV monotherapy. | 2015 | 7 |
| 15 | [Effects of transcutaneous electrostimulation of auricular concha at different stimulating frequencies and duration on acute seizures in epilepsy rats]. | 2012 | 6 |
| 16 | 2015 | 4 | |
| 17 | 2024 | 3 | |
| 18 | 2020 | 3 | |
| 19 | 2024 | 2 | |
| 20 | 2017 | 2 |
About Hong Shi
Hong Shi is a scholar working on Epidemiology, Hepatology, Cardiology and Cardiovascular Medicine, General Health Professions and Public Health, Environmental and Occupational Health, having authored 27 papers that have together received 329 indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (16 papers), Liver Disease Diagnosis and Treatment (15 papers), Hepatitis C virus research (14 papers), Acute Myocardial Infarction Research (5 papers), Cardiac Health and Mental Health (2 papers), Cardiac Arrest and Resuscitation (2 papers), Liver Disease and Transplantation (2 papers) and Protein Degradation and Inhibitors (1 paper). The work is most often cited by research in Hepatology (75 citations), Hematology (94 citations), Genetics (41 citations), Epidemiology (92 citations) and Molecular Biology (110 citations). Hong Shi has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Richard Gedrich, Amy Burd, Laura Abriola, S M Wilhelm, Hema Vasavada, David F. Miller, Dean Wilkie, W C Pickett, Daniel Auclair and Jacques Dumas. Their work appears in journals such as BioMed Research International, JAMA Network Open, Leukemia, Science Bulletin and Journal of Medical Internet Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.